论文部分内容阅读
目的:分析研究甲泼尼松龙治疗大叶性肺炎的临床效果。方法:随机选取2015年4月~2016年4月于本院就诊的106例大叶性肺炎医患人员作为研究的对象,将其依据用药的不同分为对照组(n=53)及观察组(n=53);用甲泼尼松龙,比较两组医患人员的治疗效果以及各项临床症状的消失时间。结果:观察组医患人员治疗总有效率为97.8%,对照组医患人员治疗总有效率为84.4%,数据结果对比显示差异具有统计学意义(P<0.05);观察组各项临床症状的消失时间均明显短于对照组,两组数据的对比结果显示差异具有统计学意义(P<0.05)。结论:将甲泼尼松龙用于大叶性肺炎的临床治疗当中可有效提高治疗效果以及医患人员的康复速度,故值得临床推广应用。
Objective: To analyze the clinical effect of methylprednisolone in the treatment of lobar pneumonia. Methods: A total of 106 patients with lobar pneumonia who were treated in our hospital from April 2015 to April 2016 were randomly selected and divided into control group (n = 53) and observation group (n = 53); with methylprednisolone, the treatment effect of the two groups of doctors and patients and the disappearance of the clinical symptoms were compared. Results: The total effective rate was 97.8% in the observation group and 84.4% in the control group, the difference was statistically significant (P <0.05). The clinical symptoms Disappear time were significantly shorter than the control group, the two groups of data show that the difference was statistically significant (P <0.05). Conclusion: The use of methylprednisolone in the clinical treatment of lobar pneumonia can effectively improve the treatment effect and the recovery rate of medical staff, it is worthy of clinical application.